Company / Current Liabilities per Share
Acadia Pharmaceuticals Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.66
FY2025
5-year range
$0.60 / $2.40
FY2021-FY2025
Trend
-30.7%
vs FY2024
Sector context
#78 of 210
Health Care
What the data says
At $1.66, Acadia Pharmaceuticals's current liabilities per share ranks #133 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.40 in FY2017 to $2.40 in FY2024.
Based on SEC 10-K filings.
1.66 in FY2025 with a 5-year CAGR of +19.5%.
Increased from $1.57 to $1.66 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +28.7%
- 5-Year CAGR
- +19.5%
- 10-Year CAGR
- -
Sector benchmark
#133 of 210 in Health CareTop 63% of 210This company $1.66 Sector average $15.78
▼
-89.5% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 30.7% year-over-year.
- Ranks #78 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2024.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.66 | -30.7% |
| FY2024 | $2.40 | +52.9% |
| FY2023 | $1.57 | +101.1% |
| FY2022 | $0.78 | +29.7% |
| FY2021 | $0.60 | -11.8% |
| FY2020 | $0.68 | +31.2% |
| FY2019 | $0.52 | +8.6% |
| FY2018 | $0.48 | +18.5% |
| FY2017 | $0.40 | -3.3% |
| FY2016 | $0.42 | +90.8% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026